期刊论文详细信息
BMC Nephrology
Haplotype association analysis of genes within the WNT signalling pathways in diabetic nephropathy
Gareth J McKay1  Alexander P Maxwell1  John K Crean2  Amy Jayne McKnight1  Christopher C Patterson1  David A Savage3  David H Kavanagh1 
[1] Nephrology Research Group, Centre for Public Health, Queen’s University Belfast, Belfast BT12 6BJ, UK;Conway Institute, University College Dublin, Dublin, Ireland;Histocompatibility & Immunogenetics Laboratory, Belfast Health and Social Care Trust, Belfast City Hospital, Belfast, UK
关键词: End-stage renal disease;    Association study;    WNT signalling pathway;    Diabetic nephropathy;   
Others  :  1082913
DOI  :  10.1186/1471-2369-14-126
 received in 2013-01-04, accepted in 2013-06-13,  发布年份 2013
PDF
【 摘 要 】

Background

Renal interstitial fibrosis and glomerular sclerosis are hallmarks of diabetic nephropathy (DN) and several studies have implicated members of the WNT pathways in these pathological processes. This study comprehensively examined common genetic variation within the WNT pathway for association with DN.

Methods

Genes within the WNT pathways were selected on the basis of nominal significance and consistent direction of effect in the GENIE meta-analysis dataset. Common SNPs and common haplotypes were examined within the selected WNT pathway genes in a white population with type 1 diabetes, discordant for DN (cases: n = 718; controls: n = 749). SNPs were genotyped using Sequenom or Taqman assays. Association analyses were performed using PLINK, to compare allele and haplotype frequencies in cases and controls. Correction for multiple testing was performed by either permutation testing or using false discovery rate.

Results

A logistic regression model including collection centre, duration of diabetes, and average HbA1c as covariates highlighted three SNPs in GSK3B (rs17810235, rs17471, rs334543), two in DAAM1 (rs1253192, rs1252906) and one in NFAT5 (rs17297207) as being significantly (P < 0.05) associated with DN, however these SNPs did not remain significant after correction for multiple testing. Logistic regression of haplotypes, with ESRD as the outcome, and pairwise interaction analyses did not yield any significant results after correction for multiple testing.

Conclusions

These results indicate that both common SNPs and common haplotypes of WNT pathway genes are not strongly associated with DN. However, this does not completely exclude these or the WNT pathways from association with DN, as unidentified rare genetic or copy number variants could still contribute towards the genetic architecture of DN.

【 授权许可】

   
2013 Kavanagh et al.; licensee BioMed Central Ltd.

【 预 览 】
附件列表
Files Size Format View
20141224190027235.pdf 627KB PDF download
Figure 1. 77KB Image download
【 图 表 】

Figure 1.

【 参考文献 】
  • [1]Gilg J, Castledine C, Fogarty D: Chapter 1 UK RRT incidence in 2010: national and centre-specific analyses. Nephron Clin Pract 2012, 120(Suppl 1):c1-27.
  • [2]Surendran K, Simon TC: CNP gene expression is activated by Wnt signaling and correlates with Wnt4 expression during renal injury. Am J Physiol Renal Physiol 2003, 284:F653-662.
  • [3]Surendran K, Schiavi S, Hruska KA: Wnt-dependent beta-catenin signaling is activated after unilateral ureteral obstruction, and recombinant secreted frizzled-related protein 4 alters the progression of renal fibrosis. J Am Soc Nephrol 2005, 16:2373-2384.
  • [4]He W, Dai C, Li Y, Zeng G, Monga SP, Liu Y: Wnt/beta-catenin signaling promotes renal interstitial fibrosis. J Am Soc Nephrol 2009, 20:765-776.
  • [5]Lin CL, Wang JY, Ko JY, Huang YT, Kuo YH, Wang FS: Dickkopf-1 promotes hyperglycemia-induced accumulation of mesangial matrix and renal dysfunction. J Am Soc Nephrol 2010, 21:124-135.
  • [6]Kato H, Gruenwald A, Suh JH, et al.: Wnt/β-catenin pathway in podocytes integrates cell adhesion, differentiation, and survival. J Biol Chem 2011, 286:26003-26015.
  • [7]Rooney B, O’Donovan H, Gaffney A, et al.: CTGF/CCN2 activates canonical Wnt signalling in mesangial cells through LRP6: implications for the pathogenesis of diabetic nephropathy. FEBS Lett 2011, 585:531-538.
  • [8]Ho C, Lee PH, Hsu YC, Wang FS, Huang YT, Lin CL: Sustained Wnt/β-Catenin Signaling Rescues High Glucose Induction of Transforming Growth Factor-β1-Mediated Renal Fibrosis. Am J Med Sci 2012, 344:374-382.
  • [9]Zhou T, He X, Cheng R, et al.: Implication of dysregulation of the canonical wingless-type MMTV integration site (WNT) pathway in diabetic nephropathy. Diabetologia 2012, 55:255-266.
  • [10]Hart M, Concordet JP, Lassot I, et al.: The F-box protein beta-TrCP associates with phosphorylated beta-catenin and regulates its activity in the cell. Curr Biol 1999, 9:207-210.
  • [11]Polakis P: Wnt signaling and cancer. Genes Dev 2000, 14:1837-1851.
  • [12]Grant SFA, Thorleifsson G, Reynisdottir I, et al.: Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 2006, 38:320-323.
  • [13]Saxena R, Gianniny L, Burtt NP, et al.: Common single nucleotide polymorphisms in TCF7L2 are reproducibly associated with type 2 diabetes and reduce the insulin response to glucose in nondiabetic individuals. Diabetes 2006, 55:2890-2895.
  • [14]Steinberg S, de Jong S, Andreassen OA, et al.: Common variants at VRK2 and TCF4 conferring risk of schizophrenia. Human Mol Genet 2011, 20:4076-4081.
  • [15]Habas R, Dawid IB, He X: Coactivation of Rac and Rho by Wnt/Frizzled signaling is required for vertebrate gastrulation. Gen Dev 2003, 17:295-309.
  • [16]Veeman MT, Axelrod JD, Moon RT: A second canon. Functions and mechanisms of beta-catenin-independent Wnt signaling. Dev Cell 2003, 5:367-377.
  • [17]Habas R, Dawid IB: Dishevelled and Wnt signaling: is the nucleus the final frontier? J Biol 2005, 4:2. BioMed Central Full Text
  • [18]Liu Y: New insights into epithelial-mesenchymal transition in kidney fibrosis. J Am Soc Nephrol 2010, 21:212-222.
  • [19]Ivanova L, Butt MJ, Matsell DG: Mesenchymal transition in kidney collecting duct epithelial cells. Am J Physiol Renal Physiol 2008, 294:F1238-1248.
  • [20]Ullmann U, Gilles C, De Rycke M, Van de Velde H, Sermon K, Liebaers I: GSK-3-specific inhibitor-supplemented hESC medium prevents the epithelial-mesenchymal transition process and the up-regulation of matrix metalloproteinases in hESCs cultured in feeder-free conditions. Mol Hum Reprod 2008, 14:169-179.
  • [21]Kavanagh DH, Savage DA, Patterson CC, et al.: Association analysis of canonical Wnt signalling genes in diabetic nephropathy. PLoS One 2011, 6:e23904.
  • [22]Sandholm N, Salem RM, McKnight AJ, et al.: New Susceptibility Loci Associated with Kidney Disease in Type 1 Diabetes. PLoS Genet 2012, 8:e1002921.
  • [23]Kavanagh D, McKay GJ, Patterson CC, McKnight AJ, Maxwell AP, Savage DA: Association analysis of Notch pathway signalling genes in diabetic nephropathy. Diabetologia 2011, 54:334-338.
  • [24]Perkins BA, Ficociello LH, Silva KH, Finkelstein DM, Warram JH, Krolewski AS: Regression of microalbuminuria in type 1 diabetes. N Engl J Med 2003, 348:2285-2293.
  • [25]Gabriel SB, Schaffner SF, Nguyen H, et al.: The structure of haplotype blocks in the human genome. Science 2002, 296:2225-2229.
  • [26]Purcell S, Neale B, Todd-Brown K, et al.: PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Human Genet 2007, 81:559-575.
  • [27]Liu JZ, McRae AF, Nyholt DR, et al.: A versatile gene-based test for genome-wide association studies. Am J Hum Genet 2010, 87:139-145.
  • [28]Cardon LR, Bell JI: Association study designs for complex diseases. Nat Rev Genet 2001, 2:91-99.
  文献评价指标  
  下载次数:4次 浏览次数:2次